Upcoming

Ajwa Projects IPO

BSE SME · 28–30 Oct 2026

ShareDownload cardWhatsApp
PRICE BAND₹203
GMP* —Updated 26-Oct 8:37
SUBSCRIPTION—
ISSUE VALUE₹38.05 Cr
MARKETFRAME SCORE—/100No GMP yet
Low confidence0% input coverage

Half market demand (GMP, subscription, institutional bids), half offer-document data (valuation, profit trend, fresh issue vs OFS, debt, promoters, sector). Missing inputs are left out, not guessed. Not an apply/avoid recommendation.

Unofficial GMP premium0.00%
▲ 0.00% since 24 Oct, 9:15 am
0.50.0-0.524 Oct, 9:15 am25 Oct, 7:45 am

49 archived readings. Marketframe stores its own observations; readings before we began archiving cannot be backfilled.

Subscription

No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.

GMP premium—

GMP unavailable

Subscription—

Subscription unavailable

Institutional (QIB) bids—

Not published yet

Valuation vs peers—

Not in the RHP notes yet

Profit trend—

Not in the RHP notes yet

Where the money goes—

Offer split unavailable

Balance sheet—

Not in the RHP notes yet

Promoter holding—

Not in the RHP notes yet

Sector track record—

Sector not set yet

WHERE THE MONEY GOESMARKETFRAME RHP NOTES
LOT SIZE600 shares
MINIMUM INVESTMENT₹1,21,800
AJWA PROJECTS IPO — COMMON QUESTIONSUPDATED LIVE
What is the GMP of Ajwa Projects today?

Unofficial GMP for Ajwa Projects is not available right now. Marketframe shows a GMP figure only while its source publishes one.

What is the price band of Ajwa Projects?

The price band is ₹203 per share, as reported by InvestorGain for this BSE SME issue.

When does Ajwa Projects open and close?

The issue window is 28–30 Oct 2026. The current status is upcoming.

How much is Ajwa Projects subscribed?

Live subscription figures are published by BSE once bidding opens.

Is Ajwa Projects a good IPO to apply for?

Marketframe does not publish apply or avoid calls. The Marketframe score combines market demand (GMP, subscription, institutional bids) with facts from the offer document (valuation against listed peers, profit trend, fresh issue vs OFS, debt, promoter holding and sector record). It is an automated summary of data, not a recommendation or investment advice. Read the RHP and consult a SEBI-registered adviser.

VERIFIED NOW

↑Price band published

CHECK BEFORE APPLYING

!Schedule, price and subscription are from InvestorGain, not checked against BSE

!GMP is unofficial and not verified by NSE

!Read the RHP risk factors before applying

OTHER UPCOMING IPOSLIVE BOARD

Schedule, price band and live subscription data are sourced from InvestorGain for this BSE SME issue, not directly from BSE. *GMP is sourced from InvestorGain, is unofficial and unregulated. The Marketframe score summarises market demand and offer-document data; it does not predict listing gains or returns. Marketframe does not provide investment advice. Verify every decision using SEBI, NSE, BSE and the relevant offer document.